A Survey of Darvadstrocel in People With Crohn's Disease
Recruiting · NCT05113095 · Observational (researchers observe without assigning treatment) · Lead sponsor: Takeda
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This study is a survey in Japan of Darvadstrocel injection used to treat Crohn's disease people with complicated anal fistula. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study. The main aim of the study is to check for side effects related from Darvadstrocel injection and to check if Darvadstrocel injection improves symptoms of Crohn's disease. During the study, participants with Crohn's disease will take Darvadstrocel injection according to their clinic's standard practice. The study doctors will check for side effects from Darvadstrocel for 36 months.
Who can take part
Inclusion criteria
- All patients with complex perianal fistulas in Crohn's Disease who received Darvadstrocel will be included.
Exclusion criteria
- None
Where it is running
1 location listed.
- Takeda selected site - Tokyo, Tokyo, Japan